Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Anushka Dutta

Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14

Israeli biopharma company Teva Pharmaceutical Industries Limited (TEVA) is set to replace its American Depository Shares (ADSs) with the direct listing of its ordinary shares on the NYSE. The shares will start trading on Sept. 14 after the ADSs stop trading, with the ADS-holders receiving a one-for-one exchange. The move highlights the company’s focus on United States market growth, aiming to broaden its shareholder base and optimize its cost of capital. This also opens up the potential for the stock to be included in major indices, potentially bringing greater visibility and institutional investors’ attention.

We take a closer look at Teva Pharmaceutical before that happens.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.